Sicagen Intrinsic Value
Sicagen intrinsic value. Sicagen (SICAGEN) median intrinsic value is ₹84.00 from 9 valuation models (range ₹29–₹130), vs current price ₹51.87 — +61.9% upside (Trading Below Calculated Value), margin of safety 38.3%. Compare with SICAGEN fair value to assess whether the stock is under or overvalued.
SICAGEN Valuation Methods Summary — DCF, Graham Number & P/E
Sicagen intrinsic value across 9 models vs current price ₹51.87 — upside/downside and value range per method. Read Sicagen dividend payments for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹54.24 | ₹43.39 - ₹65.09 | +4.6% | EPS: ₹4.52, Sector P/E: 12x |
| Book Value Method | asset | ₹123.75 | ₹111.38 - ₹136.12 | +138.6% | Book Value/Share: ₹123.75, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹103.74 | ₹93.37 - ₹114.11 | +100.0% | Revenue/Share: ₹281.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹84.00 | ₹75.60 - ₹92.40 | +61.9% | EBITDA: ₹56.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹129.67 | ₹103.74 - ₹155.60 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹28.93 | ₹26.04 - ₹31.82 | -44.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹37.24 | ₹33.52 - ₹40.96 | -28.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹112.18 | ₹100.96 - ₹123.40 | +116.3% | EPS: ₹4.52, BVPS: ₹123.75 |
| Dividend Yield Method | dividend | ₹28.57 | ₹25.71 - ₹31.43 | -44.9% | DPS: ₹1.00, Target Yield: 3.5% |
SICAGEN Intrinsic Value vs Market Price — All Valuation Models
Sicagen fair value range ₹29–₹130 vs current market price ₹51.87 across 9 valuation models. For current market price and key ratios, visit SICAGEN share price screener.
SICAGEN Intrinsic Value Analysis — Undervalued or Overvalued?
Sicagen median intrinsic value ₹84.00, current price ₹51.87 — Trading Below Calculated Value by 61.9%, margin of safety 38.3%.
What is the intrinsic value of SICAGEN?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sicagen (SICAGEN) is ₹84.00 (median value). With the current market price of ₹51.87, this represents a +61.9% variance from our estimated fair value.
The valuation range spans from ₹28.57 to ₹129.67, indicating ₹28.57 - ₹129.67.
Is SICAGEN undervalued or overvalued?
Based on our multi-method analysis, Sicagen (SICAGEN) appears to be trading below calculated value by approximately 61.9%.
SICAGEN Financial Health — Key Ratios vs Industry Benchmarks
Sicagen financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 26.40 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 4.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.52x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SICAGEN Cash Flow Quality — Operating & Free Cash Flow
Sicagen operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹44 Cr | ₹41 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹34 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹25 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹15 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |